Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Secondary Hyperparathyroidism in Hemodialysis
NCT00446329Phase 4Terminated
- Sponsor
- Papageorgiou General Hospital
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Papageorgiou General Hospital. Primary endpoints: Bone Mineral Density at 1 year and Bone Histology at 1 year. Started Jul 2006; status: terminated.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00446329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446329.